David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Journal of Medicine and Philosophy 30 (6):663 – 690 (2005)
I perform two analyses of the relationship across diseases between pharmaceutical innovation and the burden of disease in developed and developing countries. Both analyses indicate that the amount of pharmaceutical innovation is positively related to the burden of disease in developed countries but not to the burden of disease in developing countries. The most plausible explanation for the lack of a relationship between the burden of disease in developing countries and the amount of pharmaceutical innovation is that incentives for firms to develop medicines for diseases primarily afflicting people in developing countries have been weak or nonexistent.
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
M. J. Cherry (2009). Why Should We Compensate Organ Donors When We Can Continue to Take Organs for Free? A Response to Some of My Critics. Journal of Medicine and Philosophy 34 (6):649-673.
Similar books and articles
Loke Min Foo (2007). Third Way CR and Third World CR. International Corporate Responsibility Series 3:35-53.
Meri Koivusalo (2010). Common Health Policy Interests and the Shaping of Global Pharmaceutical Policies. Ethics and International Affairs 24 (4):395-414.
Michael J. Selgelid (2008). A Full-Pull Program for the Provision of Pharmaceuticals: Practical Issues. Public Health Ethics 1 (2):134-145.
Jorn Sonderholm (2009). In Defence of Priority Review Vouchers. Bioethics 23 (7):413-420.
Xinqing Zhang, Kenji Matsui, Benjamin Krohmal, Alaa Zeid, Vasantha Muthuswamy, Young Koo, Yoshikuni Kita & Reidar K. Lie (2010). Attitudes Towards Transfers of Human Tissue Samples Across Borders: An International Survey of Researchers and Policy Makers in Five Countries. BMC Medical Ethics 11 (1):16-.
Iain Brassington (2012). What's Wrong with the Brain Drain (?). Developing World Bioethics 12 (3):113-120.
Morgan P. Miles, Linda S. Munilla & Jeffrey G. Covin (2002). The Constant Gardener Revisited: The Effect Ofsocial Blackmail on the Marketing Concept,Innovation, and Entrepreneurship. [REVIEW] Journal of Business Ethics 41 (3):287 - 295.
G. J. Rossouw (1994). Business Ethics in Developing Countries. Business Ethics Quarterly 4 (1):43-51.
Sofia Lombera & Judy Illes (2009). The International Dimensions of Neuroethics. Developing World Bioethics 9 (2):57-64.
Anji Wall (2011). The Context of Ethical Problems in Medical Volunteer Work. HEC Forum 23 (2):79-90.
Added to index2009-01-28
Total downloads12 ( #132,704 of 1,099,722 )
Recent downloads (6 months)5 ( #64,880 of 1,099,722 )
How can I increase my downloads?